Philip Morris International Names New CEO

Before you go, we thought you'd like these...
Before you go close icon

Philip Morris International Chief Operating Officer Andre Calantzopoulos is taking over as chief executive officer of the company effective May 8, immediately following the company's annual meeting of shareholders, PMI announced Wednesday. Calantzopoulos will be taking the place of current Chairman and CEO Louis Camilleri, who will remain chairman but give up the CEO's chair on that date.

Calantzopoulos was previously president and CEO of PMI at the time when it was still a division of parent company Altria . He has worked, variously for PMI and for Altria, since 1985.

According to SEC filings, Calantzopoulos received total compensation of $15,208,950 from PMI in 2011, while Camilleri received $21,630,117. In its filing announcing the change in management , PMI advised that Calantzopoulos' and Camilleri's compensation in their new roles "will be determined by the Compensation and Leadership Development Committee of the Board of Directors at a later date and promptly announced at that time."


Shareholders are not reacting particularly well to the news today, bidding down PMI shares 0.3% to $90.55.

The article Philip Morris International Names New CEO originally appeared on Fool.com.

Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool owns shares of Philip Morris International. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners